Navigation Links
Orexigen(R) Therapeutics Announces Fourth Quarter and Year Ended December 31, 2009 Financial Results
Date:3/9/2010

nd Government Affairs, Preston Klassen, M.D., MHS as Head of the Global Contrave Program and Whedy Wang, Ph.D., MPH as Head of Global Biomedical Information.  

Contrave

Orexigen announced the results of all four of its Phase 3 trials in the Contrave Obesity Research, or COR, program in 2009.  Each trial met its co-primary endpoints. Data from these trials demonstrated the following:

  • In the COR-I and COR-II trials, approximately 48% and 56% of patients on Contrave32 lost at least 5% of their body weight after 56 weeks on an intent-to-treat basis, as compared to placebo patients who lost approximately 16% and 17% (p<0.001).  Additionally, approximately 34% to 48% of patients who completed one year of therapy on Contrave32 in these two trials lost at least 10% of their baseline body weight.
  • In the COR-BMOD trial, which incorporated an intensive diet and exercise behavior modification regimen, approximately 55% of patients who completed one year of therapy on Contrave32 lost at least 10% of their baseline body weight.
  • In the COR-Diabetes trial, patients with type 2 diabetes taking Contrave lost significantly mor
    '/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
8. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
9. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
10. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  ConvaTec today announced that it will report its 2013 first quarter ... CEO, and Ed Borkowski , CFO, will host an ... To participate in the conference call within the U.S. and ... in the conference call outside the U.S. and Canada ... Participants should dial in 10 minutes prior to the start ...
(Date:5/17/2013)... Puerto Rico , May 17, 2013 /PRNewswire/ ... western Puerto Rico , Caribbean Imaging and ... has improved its radiation therapy capabilities with the acquisition of ... Puerto Rico . Versa HD offers clinicians the versatility ... tumors throughout the body, while also enabling treatment of highly ...
(Date:5/17/2013)... Conn. , May 17, 2013  Boehringer ... in respiratory disease at the American Thoracic Society ... PA , May 17 – 22. ... product approved for the treatment of chronic obstructive ... powder)], as well as investigational compounds for asthma, ...
Breaking Medicine Technology:Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8
... Valeant Pharmaceuticals International, Inc. (NYSE: ... Valeant has agreed to acquire certain assets from ... focused on skincare products, for approximately $64 million ... revenue targets.  University Medical,s main brand is AcneFree, ...
... 3, 2012 Dutch Medical Brands receives ... Instead of traditional treatment with antibiotics, bladder and urinary ... known side effects. Dutch company Medical Brands has obtained ... Cranberry-Active capsule, making it the first and only cranberry-based ...
Cached Medicine Technology:Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical 2Cranberry Capsule Proven to Cure Bladder Infection 2
(Date:5/18/2013)... “World Healthcare IT Market: Trends & Forecast (2010 – ... and opportunities in North America, Europe, Asia, & Rest ... 89 market data tables , 20 ... , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early buyers will ... IT market is expected to grow from $99.6 billion ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 As ... courts throughout the country, Bernstein Liebhard LLP notes that ... patients often suffer tissue damage before they experience any ... according to Science Daily will appear in the Journal ... recipients underwent MRI screens of their hips. The ...
(Date:5/18/2013)... May 18, 2013 The “Sleep Apnea ... Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal ... to 2017” analyzes and studies the major market drivers, ... Rest of the World. , Browse , ... 16 Figures , 318 pagesand ...
(Date:5/18/2013)... The Ayurvedic practitioner program will be offered in ... Program is available in Mexico via Live Internet or ... practiced for over 5,000 years. In Ayurvedic medicine ( ... when an individual lives in harmony with their environment, ... aims to heal an individual in all levels (physically, ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Losing weight remains ... But among the horde of new weight loss products available ... talked about. Recent studies about this newest weight loss supplement ... ideal body shape. , Garcinia Cambogia is a sub-tropical fruit ... tamarind. Eating the fruit can suppress a person’s appetite, while ...
Breaking Medicine News(10 mins):Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2
... Wake Forest University School of Medicine has reported in ... to the aorta which may occur due to bypass ... heart which may lead to cognitive loss and the ... to the aorta reduces development of cognitive defects. ...
... wristwatch invented by South Africa's Gervan Lubbe which can detect ... hazard. They have warned that the device may contribute towards ... also expressed doubts if the watch can really perform functions ... a potential public health threat as opposed to a boon ...
... four Marlboro smokers for hi-tech screenings aimed at the early detection ... pay for spiral CT scans which is estimated at ?300. //If ... save several thousand lives as a result of early detection. The ... smoking. ,A class action status is sought by ...
... International study conducted by the University of New South ... the HIV treatment can be life threatening and resulted ... because //they identified that the patients who took a ... progression of the disease, compared with those who took ...
... teenage smokers in Alberta in 2005, when in comparison to 2004. ... are being blamed for this by anti-smoking campaigners. The young adult ... the Alberta Alcohol and Drug Abuse Commission for this state of ... of Alberta who belong to the age group of 15 years ...
... the Health Minister on the prescription issue. Under this nurses ... move has been widely criticized, but the BMA's GP committee ... statement of the Health Minister on the introduction of nurse ... who should be able to spend more time with those ...
Cached Medicine News:Health News:Breaks In The HIV Treatment Resulted In Devastating Results. 2
... The MultiBlot tray is specifically designed ... commonly used 10.16 x 13.34cm dot blot ... exterior dimensions as a standard microplate for ... and accepts commercially available dot blot membranes ...
... offers rapid and effective transfers over ... blotting area. Designed for use with ... used with the PROTEAN Plus Dodeca ... provides uniform transfers in as little ...
Mini Trans-Blot and PowerPac 300 System, 110-120 V...
... regulator. The Model 785 vacuum blotter ... from an agarose gel onto a nylon ... min for transfer, the nucleic acid samples ... to a membrane, and the hybridization reaction ...
Medicine Products: